Androgen receptor (AR) is expressed in normal breast epithelial cells and in ~70–90% of invasive breast carcinomas.1 Alternative splicing of the AR gene results in multiple transcript variants encoding different isoforms. This evidence concerns the gene AR and invasive breast carcinoma.